Global IVD Contract Manufacturing Services Market Size & Trends Report Segmented by Services (Manufacturing, Assay Development), Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics), End-user & Regional Forecast to 2030

The global IVD contract manufacturing services market is set to witness a growth rate of ~11% during the forecast period. Growing preference for point-of-care testing services; government support to scale up production of IVD kits post COVID-19 pandemic; growing incidence of cancer and infectious diseases; and advantages such as cost savings, scalability, technology know-how and risk mitigation offered by IVD contract manufacturers are some of the key factors driving the market growth.

In-vitro diagnostics (IVD) are tests done on samples such as blood or tissue to detect diseases or other conditions. It is used to monitor a persons overall health to help cure, treat, or prevent diseases. Cost savings, scalability, technology know-how, and risk mitigation offered by IVD contract manufacturers drive OEMs' decision to outsource to IVD CDMOs.

To learn more about this report, download the PDF brochure

Growing preference for point-of-care (POC) testing services fuels the growth of the IVD contract manufacturing services market

In an endeavor to cut result time and help patients make better-informed decisions about their health, there is considerable demand for IVD testing to move closer to the patient, i.e. point-of-care (POC) diagnostics, whether in the hospital, clinic, physician's office, or home. Manufacturing of specific PoC devices presents manufacturers (OEMs) with a variety of design and manufacturing challenges. For instance, the ability to process high-precision components that involve reagents and fluids are the most relevant capabilities sought by OEMs, which are accomplished by specialized IVD CDMOs.

Rising demand for point-of-care IVD devices is a key driver for growth. Recently launched point-of-care IVD instruments and devices are convenient to use and efficient.Manufacng of specific PoC devices presents manufacturers (OEMs) with a variety of design and manufacturing challenges, which is addressed by IVD CDMOs.-Director, Leading IVD OEM, United States

Cost savings, scalability, technology know-how and risk mitigation offered by IVD contract manufacturers drives their demand

By partnering with IVD contract manufacturers, OEMs can save costs on labor, automation and can achieve economies of scale at a relatively lower cost. OEMs prefer IVD CDMOs for their scalability, reliability, and cost-effective manufacturing capabilities. OEMs look for IVD CDMOs who have sound technical capabilities that are not part of their core competency. Mitigation of regulatory risks & supply disruption risks is other pivotal factors that urge OEMs to partner with IVD CDMOs. For instance,

• In January 2025, Akoya Biosciences selected Argonaut Manufacturing Services as its contract manufacturing partner to support the production of in-vitrognostic (IVD) products, aiming to accelerate commercialization and expand its IVD offerings
• In March 2024, Beckman Coulter and Fujirebio collaborated to co-develop patient-friendly, blood-based Alzheimers disease tests, leveraging Fujirebios IVD expertise and manufacturing capabilities

Growing incidence of cancer and infectious diseases & role of IVDs drives theIVD contract manufacturing services market

IVD plays a critical role in driving clinical decision-making for cancer screening, diagnosis, and treatment. IVD testing provides insights related to a patients health status such as risk or predisposition for developing certain cancer; the stage of disease, and the prognosis for progression/remission after therapy.

IVDs are also used to analyze human samples such as blood and saliva. It helps in measuring the concentration of specific substances/analytes, detects the presence or absence of a particular marker or set of markers in responseection. Clinicians frequently use IVDs to diagnose infectious diseases, guide treatment decisions and even mitigate or prevent future diseases. Continuously rising cases of cancer and infectious diseases are likely to spur the IVD contract manufacturing services market.

To learn more about this report, download the PDF brochure

Competitive Landscape Analysis

The IVD Contract Manufacturing Services market is marked by the presence of key players such as Jabil Inc., STRATEC, Celestica, Sanmina Corporation, Rchling, KMC Systems, Savyon Diagnostics, Nova Biomedical, Cone Bioproducts, Thermo Fisher Scientific Inc., Cenogenics Corporation, Coris BioConcept, Gerresheimer, and Phillips-Medisize, among others. Some of the key strategies adopted by market players include strategic partnerships and collaborations and geographic expansion.

Report Scope

Global IVD Contract Manufacturing Services Market Segmentation

This report by Medi-Tech Insights provides the size of the global IVD contract manufacturing services market at the regional- and country-level from 2023 to 2030. The report further segments the market based on service, technology, and end-user.

Market Size & Forecast (2023-2030), By Service, USD Million

• Manufacturing Services
• Assay Development Services
• Others

Market Size & Forecast (2023-2030), By Technology, USD Million

• Immunoassays
• Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Microbiology
• Coagulation
• Others

Market Size & Forecast (2023-2030), By End-user, USD Million

• Medical Device Comies
• Academic & Research Institutes
• Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Key Strategic Questions Addressed

• What is the market size & forecast of the IVD Contract Manufacturing Services market?
• What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the IVD Contract Manufacturing Services market?
• What are the key trends defining the market?
• What are the major factors impacting the market?
• What are the opportunities prevailing in the market?
• Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
• Who are the major players operating in the market?
• What are the key strategies adopted by players?